Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


Articles published in Alzheimer Dis Assoc Disord

Retrieve available abstracts of 103 articles:
HTML format



Single Articles


    May 2024
  1. MORIN P, Aguilar BJ, Berlowitz D, Zhang R, et al
    Clinical Characterization of Veterans With Alzheimer Disease by Disease Severity in the United States.
    Alzheimer Dis Assoc Disord. 2024 May 17. doi: 10.1097/WAD.0000000000000622.
    PubMed     Abstract available


  2. BRIGGS AQ, Ouedraogo Tall S, Boza-Calvo C, Bernard MA, et al
    Drivers of Memory Loss Underreport in Mild Cognitive Impairment Due to Alzheimer Versus Vascular Disease.
    Alzheimer Dis Assoc Disord. 2024 May 17. doi: 10.1097/WAD.0000000000000627.
    PubMed     Abstract available


  3. HAGHDEL A, Smith N, Glodzik L, Li Y, et al
    Evidence of Pericyte Damage in a Cognitively Normal Cohort: Association With CSF and PET Biomarkers of Alzheimer's Disease.
    Alzheimer Dis Assoc Disord. 2024 May 16. doi: 10.1097/WAD.0000000000000623.
    PubMed     Abstract available


  4. TERESI JA, Ocepek-Welikson K, Eimicke JP, Ramirez M, et al
    Measurement of Allostatic Load in Caregivers of Older Hispanic People With Alzheimer Disease and Related Disorders.
    Alzheimer Dis Assoc Disord. 2024 May 16. doi: 10.1097/WAD.0000000000000625.
    PubMed     Abstract available


    April 2024
  5. JUNG NY, Je Y, Ham HG, Park YH, et al
    Comparison of Enlarged Perivascular Spaces in Early-Onset and Late-Onset Alzheimer Disease-related Cognitive Impairment: A Single Clinic-based Study in South Korea.
    Alzheimer Dis Assoc Disord. 2024 Apr 2. doi: 10.1097/WAD.0000000000000614.
    PubMed     Abstract available


    January 2024
  6. FREDERIKSEN KS, Morato X, Zetterberg H, Gauthier S, et al
    Focusing on Earlier Management of Alzheimer Disease: Expert Opinion Based on a Modified Nominal Group Technique.
    Alzheimer Dis Assoc Disord. 2024 Jan 29. doi: 10.1097/WAD.0000000000000600.
    PubMed     Abstract available


  7. D'SOUZA GM, Churchill NW, Guan DX, Khoury MA, et al
    Interaction of Alzheimer Disease and Traumatic Brain Injury on Cortical Thickness.
    Alzheimer Dis Assoc Disord. 2024 Jan 29. doi: 10.1097/WAD.0000000000000607.
    PubMed     Abstract available


  8. KOBAYASHI R, Morioka D, Kawakatsu S, Sakamoto K, et al
    Application of Suggestive Biomarkers in Dementia With Lewy Bodies With Masking of Typical Clinical Symptoms by Alzheimer Disease-type Pathology.
    Alzheimer Dis Assoc Disord. 2024 Jan 17. doi: 10.1097/WAD.0000000000000597.
    PubMed     Abstract available


  9. WERNER P, Ulitsa N, Alpinar-Sencan Z, Shefet D, et al
    Identifying Stigmatizing Language Used by Israelis and Germans With a Mild Neurocognitive Disorder, Their Relatives, and Caregivers of People With Alzheimer's Disease.
    Alzheimer Dis Assoc Disord. 2024 Jan 9. doi: 10.1097/WAD.0000000000000596.
    PubMed     Abstract available


  10. SEWELL M, Neugroschl J, Zhu CW, Loizos M, et al
    Lessons From the Coronavirus Disease Experience: Research Participant and Staff Satisfaction With Remote Cognitive Evaluations.
    Alzheimer Dis Assoc Disord. 2024;38:65-69.
    PubMed     Abstract available


  11. SABBAGH MN, Michalak W, Thim Hansen C, Ahmad Wichmann C, et al
    Rescreening on RBANS Delayed Memory Index? Forget About It!
    Alzheimer Dis Assoc Disord. 2024;38:8-13.
    PubMed     Abstract available


  12. STITES SD, Lee BN, Rubright JD, Harkins K, et al
    Cognitive Complaint Types Can Correlate With Cognitive Testing, Perceived Stress, and Symptom Distress in Older Adults With Normal Cognition and Dementia.
    Alzheimer Dis Assoc Disord. 2024;38:34-41.
    PubMed     Abstract available


    November 2023
  13. BELFORT ALMEIDA DOS SANTOS TT, Nogueira MML, Lacerda IB, Brandt M, et al
    A Longitudinal Evaluation of the Pattern of Social Cognition Impairment in Brazilians With Alzheimer's Disease.
    Alzheimer Dis Assoc Disord. 2023 Nov 2. doi: 10.1097/WAD.0000000000000588.
    PubMed     Abstract available


    October 2023
  14. CLARK LR, Erickson CM, Chin NA, Basche KE, et al
    Anticipated Psychological or Behavioral Reactions to Learning Alzheimer Biomarker Results: Associations With Contextual Factors.
    Alzheimer Dis Assoc Disord. 2023 Oct 12. doi: 10.1097/WAD.0000000000000586.
    PubMed     Abstract available


  15. RAZOUQI Y, El Bouchikhi I, El-Abid H, Baammi S, et al
    Novel APOE Mutation in a Moroccan Subject Suffering from Alzheimer Disease: A Case Study and Exploration of Pathogenic Implication.
    Alzheimer Dis Assoc Disord. 2023;37:370-372.
    PubMed     Abstract available


  16. PLASCHKE K, Kopitz J, Gebert J, Wolf ND, et al
    Proteomic Analysis Reveals Potential Exosomal Biomarkers in Patients With Sporadic Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2023;37:315-321.
    PubMed     Abstract available


  17. MEMBRENO R, Thomas KR, Calcetas AT, Edwards L, et al
    Regional White Matter Hyperintensities Relate to Specific Cognitive Abilities in Older Adults Without Dementia.
    Alzheimer Dis Assoc Disord. 2023;37:303-309.
    PubMed     Abstract available


  18. HONIG LS
    Alzheimer Disease: A New Beginning in Therapeutics.
    Alzheimer Dis Assoc Disord. 2023;37:267-269.
    PubMed    


  19. RAHMAN-FILIPIAK A, Lesniak M, Sadaghiyani S, Roberts S, et al
    Perspectives From Black and White Participants and Care Partners on Return of Amyloid and Tau PET Imaging and Other Research Results.
    Alzheimer Dis Assoc Disord. 2023;37:274-281.
    PubMed     Abstract available


  20. CONCEICAO ASGG, Sant Ana LFG, Mattar GP, de Fatima R Silva M, et al
    Balance and Gait: Associations With Cognitive Impairment and Dementia in Individuals With Down Syndrome.
    Alzheimer Dis Assoc Disord. 2023;37:349-356.
    PubMed     Abstract available


  21. REDFORD E, Heuer S
    A Visual Analog Scale for Self-Reported Quality of Life: A Comparison of VAS and QoL-AD in Older Adults.
    Alzheimer Dis Assoc Disord. 2023;37:343-348.
    PubMed     Abstract available


  22. KANN MR, Zeiger PJ, Rizer SJ, Cosentino S, et al
    Virtual Assessment as a Way to Reduce Help-seeking Barriers in Older Adults With Subjective Cognitive Decline.
    Alzheimer Dis Assoc Disord. 2023;37:373-378.
    PubMed     Abstract available


  23. PLETNIKOVA A, Okhravi HR, Jamil N, Kirby M, et al
    Utility of amyloid PET Imaging in a Memory Clinic.
    Alzheimer Dis Assoc Disord. 2023;37:270-273.
    PubMed     Abstract available


    September 2023
  24. SCHUBERT CR, Paulsen AJ, Pinto AA, Chappell RJ, et al
    Effect of Neurotoxin Exposure on Blood Biomarkers of Neurodegeneration and Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2023 Sep 13. doi: 10.1097/WAD.0000000000000579.
    PubMed     Abstract available


  25. SABBAGH MN, Mathew P, Blau A
    A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers.
    Alzheimer Dis Assoc Disord. 2023 Sep 11. doi: 10.1097/WAD.0000000000000578.
    PubMed     Abstract available


    August 2023
  26. PROUGH MB, Zaman A, Caywood LJ, Clouse JE, et al
    Visuospatial and Verbal Memory Differences in Amish Individuals with Alzheimer Disease and Related Dementias.
    Alzheimer Dis Assoc Disord. 2023 Aug 2. doi: 10.1097/WAD.0000000000000570.
    PubMed     Abstract available


    July 2023
  27. STRIJKERT F, Huitema RB, van Munster BC, Spikman JM, et al
    Impaired Emotion Recognition: A Potential Marker for Social Behavioral Problems in Patients with Amnestic Mild Cognitive Impairment and Early Alzheimer Disease?
    Alzheimer Dis Assoc Disord. 2023 Jul 24. doi: 10.1097/WAD.0000000000000567.
    PubMed     Abstract available


  28. TIDMORE LM, Skrepnek GH
    To the Editor and Readership of Alzheimer Disease and Associated Disorders.
    Alzheimer Dis Assoc Disord. 2023 Jul 5. doi: 10.1097/WAD.0000000000000566.
    PubMed    


  29. KAWADA T
    A National Assessment of Alzheimer Disease and Antipsychotic Medication Prescribing Among Older Adults in Ambulatory Care Settings.
    Alzheimer Dis Assoc Disord. 2023 Jul 5. doi: 10.1097/WAD.0000000000000565.
    PubMed    


  30. CHI YC, Chu WM, Chang HY, Lu TH, et al
    International Variations in Dementia and Alzheimer Disease Diagnosis and Certification Habits and Their Associations With Dementia and Alzheimer Disease Mortality: A Cross-Sectional Study of 38 Countries.
    Alzheimer Dis Assoc Disord. 2023;37:215-221.
    PubMed     Abstract available


    June 2023
  31. TAYEB HO, Butt NS, Khallaf R, Yahghmour B, et al
    Alzheimer's Behavioral and Psychiatric Burden in Saudi Arabia: Validation of the Saudi Version of the Neuropsychiatric Inventory.
    Alzheimer Dis Assoc Disord. 2023 Jun 26. doi: 10.1097/WAD.0000000000000563.
    PubMed     Abstract available


  32. SUGIMURA Y, Baba T, Ezura M, Kikuchi A, et al
    A Case of Corticobasal Syndrome and Posterior Cortical Atrophy With Biomarkers of Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2023 Jun 22. doi: 10.1097/WAD.0000000000000560.
    PubMed     Abstract available


    April 2023
  33. AMIRI S, Jiang L, Manson SM, Buchwald DS, et al
    Trends in Alzheimer Disease Mortality Among American Indian and Alaska Native People Between 2011 and 2019.
    Alzheimer Dis Assoc Disord. 2023 Apr 28. doi: 10.1097/WAD.0000000000000555.
    PubMed     Abstract available


  34. SADHUKHAN D, Mallick A, Mishra S, Mukherjee A, et al
    An Indian Young-onset Dementia With Parkinsonism With Double Heterozygous Mutations in ABCA7 and PRKN Identified Through Whole-exome Sequencing.
    Alzheimer Dis Assoc Disord. 2023;37:164-167.
    PubMed     Abstract available


  35. VAN HEZIK-WESTER VJ, Handels RLH, Wolfs CAG, Kanters TA, et al
    Caregiver Burden and Quality of Life Across Alzheimer's Disease Severity Stages.
    Alzheimer Dis Assoc Disord. 2023;37:134-141.
    PubMed     Abstract available


  36. GABEL M, Denny A, Llibre-Guerra J, Morris JC, et al
    Remuneration and Recruitment of Study Participants for AD Cohort Studies From the General Public and From Minority Communities.
    Alzheimer Dis Assoc Disord. 2023;37:107-112.
    PubMed     Abstract available


  37. SHAW AR, Lofton S, Vidoni ED
    A Virtual Photovoice Study of Older African Americans Perceptions of Neurovascular Clinical Trials.
    Alzheimer Dis Assoc Disord. 2023;37:113-119.
    PubMed     Abstract available


  38. MASCARENHAS FONSECA L, Sheppard DP, Chaytor NS
    MoCA Intraindividual Cognitive Variability in Older Adults With Type 1 Diabetes.
    Alzheimer Dis Assoc Disord. 2023;37:152-155.
    PubMed     Abstract available


    February 2023
  39. SO RJ, Biju K, Oh E, Rosenberg P, et al
    Characterization of Balance Control and Postural Stability in Patients With Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2023 Feb 20. doi: 10.1097/WAD.0000000000000548.
    PubMed     Abstract available


    January 2023
  40. PAGANINI-HILL A, Bukhari S, Montine TJ, Corrada MM, et al
    Alzheimer's Disease Neuropathologic Change and Vitamin Supplement Use Decades Earlier: The 90+ Study.
    Alzheimer Dis Assoc Disord. 2023;37:1-6.
    PubMed     Abstract available


  41. CALVO N, Anderson JAE, Berkes M, Freedman M, et al
    Gray Matter Volume as Evidence for Cognitive Reserve in Bilinguals With Mild Cognitive Impairment.
    Alzheimer Dis Assoc Disord. 2023;37:7-12.
    PubMed     Abstract available


  42. JIN L, Nawaz H, Ono K, Nowell J, et al
    One Minute of EEG Data Provides Sufficient and Reliable Data for Identifying Lewy Body Dementia.
    Alzheimer Dis Assoc Disord. 2023;37:66-72.
    PubMed     Abstract available


  43. KELLY MJ, Fearon C, O'Dowd S
    Seeing the Woods for the Trees? Applying Diagnostic Criteria for Dementia with Lewy Bodies to Patients Presenting with Posterior Cortical Atrophy.
    Alzheimer Dis Assoc Disord. 2023;37:88-91.
    PubMed     Abstract available


  44. THOMAS Q, Nambot S, Bejot Y, Philippe C, et al
    A New Presenilin-1 Missense Variant Associated With a Progressive Supranuclear Palsy-like Phenotype.
    Alzheimer Dis Assoc Disord. 2023;37:82-84.
    PubMed     Abstract available


    November 2022
  45. FLEISHER JE, Moshkovich A, Levin M, Akram F, et al
    Family Caregiver Comorbidities in Lewy Body Dementia Versus Alzheimer Disease and Associated Disorders.
    Alzheimer Dis Assoc Disord. 2022 Nov 9. pii: 00002093-990000000-00034.
    PubMed     Abstract available


    October 2022
  46. KELEMAN AA, Chang CH, Bollinger RM, Lingler JH, et al
    Psychometric Evaluation of the Perceived Research Burden Assessment (PeRBA) in Longitudinal Studies of Alzheimer Disease Using Rasch Analysis.
    Alzheimer Dis Assoc Disord. 2022 Oct 14. pii: 00002093-990000000-00031.
    PubMed     Abstract available


  47. LEHTOLA JM, Karkkainen V, Andberg S, Hannonen S, et al
    Computer-based Eye-tracking Analysis of King-Devick Test Differentiates Persons With Idiopathic Normal Pressure Hydrocephalus From Cognitively Unimpaired.
    Alzheimer Dis Assoc Disord. 2022;36:340-346.
    PubMed     Abstract available


  48. ZHANG Q, Li J, Quan W, Liu L, et al
    CSF alpha-Synuclein and Tau as Biomarkers for Dementia With Lewy Bodies: A Systematic Review and Meta-analysis.
    Alzheimer Dis Assoc Disord. 2022;36:368-373.
    PubMed     Abstract available


  49. CHAPMAN S, Weiss D, Broulikova HM, Sunderaraman P, et al
    Examining the Role of Aging Perceptions in Subjective Cognitive Decline.
    Alzheimer Dis Assoc Disord. 2022;36:288-294.
    PubMed     Abstract available


  50. GABEL M, Bollinger RM, Knox M, Coble DW, et al
    Perceptions of Research Burden and Retention Among Participants in ADRC Cohorts.
    Alzheimer Dis Assoc Disord. 2022;36:281-287.
    PubMed     Abstract available


  51. CISTARO A, Quartuccio N, Cassalia L, Vai D, et al
    Brain 18 F-Florbetapir PET/CT Findings in an Early-onset Alzheimer Disease Patient Carrying Presenilin-1 G378E Mutation.
    Alzheimer Dis Assoc Disord. 2022;36:347-349.
    PubMed     Abstract available


    September 2022
  52. MAKRAKIS D, Holt SK, Bernick C, Grivas P, et al
    Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer: Results From an Administrative Dataset.
    Alzheimer Dis Assoc Disord. 2022 Sep 30. pii: 00002093-990000000-00029.
    PubMed     Abstract available


    August 2022
  53. LIU Z, Grant J, Simpson SP, Khattak A, et al
    Driving Ability Evaluation and Rehabilitation for People With Alzheimer's Disease and Related Dementias.
    Alzheimer Dis Assoc Disord. 2022 Aug 19. pii: 00002093-990000000-00022.
    PubMed     Abstract available


    July 2022
  54. FUJISAWA C, Saji N, Takeda A, Kato T, et al
    Early-onset Alzheimer Disease Associated With Neuromyelitis Optica Spectrum Disorder.
    Alzheimer Dis Assoc Disord. 2022 Jul 18. pii: 00002093-990000000-00015.
    PubMed     Abstract available


  55. JOSHI H, Shah J, Abu-Hijleh FA, Patel V, et al
    Decreased Expression of Cerebral Dopamine Neurotrophic Factor in Platelets of Probable Alzheimer Patients.
    Alzheimer Dis Assoc Disord. 2022;36:269-271.
    PubMed     Abstract available


  56. KIM HJ, Jo S, Lee S, Oh M, et al
    Crossed Hemispheric Accumulation of beta-Amyloid and Tau Protein in a Patient With Typical Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2022;36:263-265.
    PubMed     Abstract available


    June 2022
  57. TIDMORE LM, Skrepnek GH
    A National Assessment of Alzheimer Disease and Antipsychotic Medication Prescribing Among Older Adults in Ambulatory Care Settings.
    Alzheimer Dis Assoc Disord. 2022 Jun 7. pii: 00002093-990000000-00010.
    PubMed     Abstract available


    May 2022
  58. DOHERTY T, Gee M, Maruff P, Smith R, et al
    Increasing the Cognitive Screening Efficiency of Global Phase III Trials in Early Alzheimer Disease: The Cognitive Task Force.
    Alzheimer Dis Assoc Disord. 2022 May 10. pii: 00002093-990000000-00007.
    PubMed     Abstract available


    April 2022
  59. HAKHU NR, Gillen DL, Grill JD
    Dyadic Enrollment in a Phase 3 Mild Cognitive Impairment Clinical Trial.
    Alzheimer Dis Assoc Disord. 2022 Apr 29. pii: 00002093-990000000-00006.
    PubMed     Abstract available


  60. STREITZ ML, Denny A, Xiong C, McCue L, et al
    Development of a Comprehensive Battery to Collect Social and Structural Determinants of Health (SSDOH) in Cognitively Normal or Very Mildly Impaired Persons.
    Alzheimer Dis Assoc Disord. 2022;36:97-102.
    PubMed     Abstract available


  61. ASTOLFI NEVES B, Villela Nunes P, Diehl Rodriguez R, Medeiros Haidar A, et al
    Cause of Death Determined by Full-body Autopsy in Neuropathologically Diagnosed Dementias: The Biobank for Aging Studies of the University of Sao Paulo (BAS-USP), Brazil.
    Alzheimer Dis Assoc Disord. 2022;36:156-161.
    PubMed     Abstract available


    March 2022
  62. EL HAJ M, Allain P, Antoine P, Chapelet G, et al
    The "Sickness" Memory: Can Patients With Alzheimer Disease Remember the Diagnosis Announcement?
    Alzheimer Dis Assoc Disord. 2022 Mar 30. pii: 00002093-990000000-00001.
    PubMed     Abstract available


  63. GALLUZZI S, Mega A, Di Fede G, Muscio C, et al
    Psychological Impact of Predictive Genetic Testing for Inherited Alzheimer Disease and Frontotemporal Dementia: The IT-DIAfN Protocol.
    Alzheimer Dis Assoc Disord. 2022 Mar 16. pii: 00002093-900000000-99191.
    PubMed     Abstract available


  64. REYNOLDS GO, Tremont G, Santorelli GD, Denby C, et al
    Healthy Lifestyle Behaviors and Viewpoints Among Members of an Alzheimer Prevention Registry.
    Alzheimer Dis Assoc Disord. 2022 Mar 15. pii: 00002093-900000000-99194.
    PubMed     Abstract available


    February 2022
  65. ORTEGA-ROJAS J, Arboleda-Bustos CE, Guerrero E, Neira J, et al
    Genetic Variants and Haplotypes of TOMM40, APOE, and APOC1 are Related to the Age of Onset of Late-onset Alzheimer Disease in a Colombian Population.
    Alzheimer Dis Assoc Disord. 2022 Feb 11. pii: 00002093-900000000-99195.
    PubMed     Abstract available


  66. ERICKSON CM, Chin NA, Ketchum FB, Jonaitis EM, et al
    Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results.
    Alzheimer Dis Assoc Disord. 2022 Feb 4. pii: 00002093-900000000-99198.
    PubMed     Abstract available


    January 2022
  67. DE SOUZA NAP, de Oliveira F, de Carvalho RLS, Dourado MCN, et al
    The Relationship Between Decision-making Capacity and the Domains of Awareness in Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2022 Jan 28. pii: 00002093-900000000-99199.
    PubMed     Abstract available


  68. VAN DER DOELEN DM, Handels RLH, Zwan MD, van Kuijk SMJ, et al
    The Impact of Amyloid PET Disclosure on Quality of Life in Patients With Young Onset Dementia.
    Alzheimer Dis Assoc Disord. 2022;36:1-6.
    PubMed     Abstract available


    December 2021
  69. DE GUISE E, Soucy B, Joubert S, Correa JA, et al
    Risk Factors for Alzheimer Disease Development After Traumatic Brain Injury: A Preliminary Study.
    Alzheimer Dis Assoc Disord. 2021 Dec 30. pii: 00002093-900000000-99208.
    PubMed     Abstract available


  70. LEVINE TF, Roe CM, Babulal GM, Fagan AM, et al
    Limited Longitudinal Change in Self-reported Spatial Navigation Ability in Preclinical Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2021 Dec 30. pii: 00002093-900000000-99207.
    PubMed     Abstract available


  71. COTHRAN FA, Alto R, Tomaszewski Farias S, Johnson DK, et al
    Caring for the Caregivers: An Alzheimer Disease Research Center Call to Action.
    Alzheimer Dis Assoc Disord. 2021 Dec 30. pii: 00002093-900000000-99206.
    PubMed     Abstract available


  72. BOEDEKER S, Halstenberg E, Schulz P, Beblo T, et al
    Impaired Color Discrimination in Alzheimer Disease Dementia.
    Alzheimer Dis Assoc Disord. 2021 Dec 2. pii: 00002093-900000000-99210.
    PubMed     Abstract available


    October 2021
  73. FU J, Ji X, Liu J, Chen X, et al
    Meta-analysis of the Connection Between Alzheimer Disease and Telomeres.
    Alzheimer Dis Assoc Disord. 2021 Oct 15. pii: 00002093-900000000-99214.
    PubMed     Abstract available


  74. BASTIN C, Bahri MA, Giacomelli F, Mievis F, et al
    Familiarity in Mild Cognitive Impairment as a Function of Patients' Clinical Outcome 4 Years Later.
    Alzheimer Dis Assoc Disord. 2021;35:321-326.
    PubMed     Abstract available


  75. APPIAH F, Charnigo RJ
    A Comparison of Methods for Predicting Future Cognitive Status: Mixture Modeling, Latent Class Analysis, and Competitors.
    Alzheimer Dis Assoc Disord. 2021;35:306-314.
    PubMed     Abstract available


  76. KIM HJ, Cheong EN, Jo S, Lee S, et al
    Early Impairment in the Ventral Visual Pathway Can Predict Conversion to Dementia in Patients With Amyloid-negative Amnestic Mild Cognitive Impairment.
    Alzheimer Dis Assoc Disord. 2021;35:298-305.
    PubMed     Abstract available


  77. JOSHI P, Gardner M, Lintott C, Anderson T, et al
    Novel Presenilin-1 Mutation (Ala275Ser) Associated With Clinical Features of Dementia With Lewy Bodies.
    Alzheimer Dis Assoc Disord. 2021;35:350-352.
    PubMed     Abstract available


    August 2021
  78. EZZATI A, Zammit AR, Lipton RB
    Comparing Performance of Different Predictive Models in Estimating Disease Progression in Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2021 Aug 16. pii: 00002093-900000000-99219.
    PubMed     Abstract available


    July 2021
  79. WANG T, Guo Z, Du Y, Xiong M, et al
    Effects of Noninvasive Brain Stimulation (NIBS) on Cognitive Impairment in Mild Cognitive Impairment and Alzheimer Disease: A Meta-analysis.
    Alzheimer Dis Assoc Disord. 2021;35:278-288.
    PubMed     Abstract available


  80. PACHI I, Evans AH, Loi SM, Eratne D, et al
    Odor Identification Testing Can Assist in the Clinical Distinction Between Psychiatric Disorders and Neurological/Neurodegenerative Disorders.
    Alzheimer Dis Assoc Disord. 2021;35:244-249.
    PubMed     Abstract available


  81. KAUFMAN CS, Morris JK, Vidoni ED, Burns JM, et al
    Apolipoprotein E4 Moderates the Association Between Vascular Risk Factors and Brain Pathology.
    Alzheimer Dis Assoc Disord. 2021;35:223-229.
    PubMed     Abstract available


  82. FRIZ AM, Benson C, Mullen S, Block L, et al
    Tailoring Research Recruitment for Acute Care Settings: Recommendations from People with Dementia and their Caregivers.
    Alzheimer Dis Assoc Disord. 2021;35:191-199.
    PubMed     Abstract available


    May 2021
  83. LI XY, Cui Y, Jing D, Xie K, et al
    Novel PSEN1 and PSEN2 Mutations Identified in Sporadic Early-onset Alzheimer Disease and Posterior Cortical Atrophy.
    Alzheimer Dis Assoc Disord. 2021 May 11. pii: 00002093-900000000-99233.
    PubMed     Abstract available


  84. SYKORA D, Stonnington CM, Jain N
    An Agitated Patient With COVID-19 Infection and Early-onset Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2021 May 11. pii: 00002093-900000000-99231.
    PubMed     Abstract available


    April 2021
  85. LOIZOS M, Neugroschl J, Zhu CW, Li C, et al
    Adapting Alzheimer Disease and Related Dementias Clinical Research Evaluations in the Age of COVID-19.
    Alzheimer Dis Assoc Disord. 2021 Apr 26. pii: 00002093-900000000-99236.
    PubMed     Abstract available


  86. KIM HR, Lee T, Choi JK, Jeong Y, et al
    Polymorphism in the MAGI2 Gene Modifies the Effect of Amyloid beta on Neurodegeneration.
    Alzheimer Dis Assoc Disord. 2021;35:114-120.
    PubMed     Abstract available


    March 2021
  87. ERYILMAZ IE, Bakar M, Egeli U, Cecener G, et al
    Evaluation of the Clinical Features Accompanied by the Gene Mutations: The 2 Novel PSEN1 Variants in a Turkish Early-onset Alzheimer Disease Cohort.
    Alzheimer Dis Assoc Disord. 2021 Mar 24. pii: 00002093-900000000-99239.
    PubMed     Abstract available


  88. AL-THANI HF, Ahmad MN, Younes S, Zayed H, et al
    Genetic Variants Associated With Alzheimer Disease in the 22 Arab Countries: A Systematic Review.
    Alzheimer Dis Assoc Disord. 2021 Mar 23. pii: 00002093-900000000-99240.
    PubMed     Abstract available


    January 2021
  89. GARCIA-MEJIA KA, Custodio-Chable SJ, Vazquez-Franco JE, Reyes-Maldonado E, et al
    beta-Amyloid Orchestrates Factor XII and Platelet Activation Leading to Endothelial Dysfunction and Abnormal Fibrinolysis in Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2021 Jan 27. pii: 00002093-900000000-99250.
    PubMed     Abstract available


  90. RINGMAN JM, Joe E, Sheikh-Bahaei N, Miller C, et al
    Cerebral Amyloid Angiopathy-related Inflammation Presenting With a Cystic Lesion in Young-onset Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2021 Jan 20. pii: 00002093-900000000-99251.
    PubMed     Abstract available


  91. GIANNOULI V, Tsolaki M
    Mild Alzheimer Disease, Financial Capacity, and the Role of Depression: Eyes Wide Shut?
    Alzheimer Dis Assoc Disord. 2021 Jan 11. pii: 00002093-900000000-99254.
    PubMed     Abstract available


  92. GARCIA-MEJIA KA, Custodio-Chable SJ, Vazquez-Franco JE, Reyes-Maldonado E, et al
    beta-Amyloid Orchestrates Factor XII and Platelet Activation Leading to Endothelial Dysfunction and Abnormal Fibrinolysis in Alzheimer Disease.
    Alzheimer Dis Assoc Disord. 2021;35:91-97.
    PubMed     Abstract available


  93. VLACHOS GS, Kosmidis MH, Yannakoulia M, Dardiotis E, et al
    Dementia Incidence in the Elderly Population of Greece: Results From the HELIAD Study.
    Alzheimer Dis Assoc Disord. 2021;35:48-54.
    PubMed     Abstract available


  94. NGUYEN XV, Candemir S, Erdal BS, White RD, et al
    Predicting Mental Decline Rates in Mild Cognitive Impairment From Baseline MRI Volumetric Data.
    Alzheimer Dis Assoc Disord. 2021;35:1-7.
    PubMed     Abstract available


  95. GOMBOSEV A, Salazar CR, Hoang D, Cox CG, et al
    Direct Mail Recruitment to a Potential Participant Registry.
    Alzheimer Dis Assoc Disord. 2021;35:80-83.
    PubMed     Abstract available


    December 2020
  96. MURATA S, Ono R, Sugimoto T, Toba K, et al
    Functional Decline and Body Composition Change in Older Adults With Alzheimer Disease: A Retrospective Cohort Study at a Japanese Memory Clinic.
    Alzheimer Dis Assoc Disord. 2020 Dec 14. doi: 10.1097/WAD.0000000000000426.
    PubMed     Abstract available


  97. BARDACH SH, Langbaum JB, Kebodeaux CS, Jicha GA, et al
    Real-world Site Experiences With GeneMatch: The Role of a Recruitment-related Registry in the Context of Local Site Effort to Support Alzheimer Disease Prevention Research.
    Alzheimer Dis Assoc Disord. 2020 Dec 2. doi: 10.1097/WAD.0000000000000425.
    PubMed     Abstract available


    October 2020
  98. RYAN MM, Cox CG, Witbracht M, Hoang D, et al
    Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer Disease Clinical Trial Recruitment.
    Alzheimer Dis Assoc Disord. 2020 Oct 14. doi: 10.1097/WAD.0000000000000421.
    PubMed     Abstract available


  99. FUNNELL C, Feldman HH, Mackenzie IRA, DeMarco ML, et al
    Applying the Alzheimer Disease ATN Diagnostic Framework in Atypical Dementia.
    Alzheimer Dis Assoc Disord. 2020;34:357-359.
    PubMed     Abstract available


    September 2020
  100. GOMEZ-GALLEGO M, Gallego-Mellado M, Gomez-Gallego JC, Gomez-Garcia JG, et al
    Sex Moderates the Relationship of Stress and Perceived Social Support With Neuropsychological Symptoms Among Community-dwelling Persons With Alzheimer Disease in Spain.
    Alzheimer Dis Assoc Disord. 2020 Sep 30. doi: 10.1097/WAD.0000000000000416.
    PubMed     Abstract available


  101. HENG LC, Lim SH, Foo H, Kandiah N, et al
    Confluent White Matter in Progression to Alzheimer Dementia.
    Alzheimer Dis Assoc Disord. 2020 Sep 30. doi: 10.1097/WAD.0000000000000409.
    PubMed     Abstract available


  102. KISELICA AM, Kaser AN, Benge JF
    An Initial Empirical Operationalization of the Earliest Stages of the Alzheimer's Continuum.
    Alzheimer Dis Assoc Disord. 2020 Sep 21. doi: 10.1097/WAD.0000000000000408.
    PubMed     Abstract available


    January 2020
  103. BARRETT B, Schultz SK, Luther SL, Friedman Y, et al
    Mortality and Associated Risk Factors in Community-Dwelling Persons With Early Dementia.
    Alzheimer Dis Assoc Disord. 2020;34:40-46.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.